An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its ...

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (RomvimzaTM) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue ...

The Oncology Institute, Inc. (NASDAQ:TOI – Get Free Report) dropped 6.9% on Thursday . The stock traded as low as $0.88 and last traded at $0.89. Approximately 259,349 shares were traded during ...

Margolin Bros. Engineering and Consulting provides a behind-the-scenes look at one of the most impressive projects in the ...

On 4 February 2025, the global community observed World Cancer Day, a time to raise awareness about cancer prevention, ...

RefleXion Medical, a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer ...

This vulvar tumour case highlights the need for multidisciplinary care to manage coexisting malignancies and infections.

Q3 2025 Management View CEO Jim Frakes noted that Aethlon Medical has made significant progress in focusing on oncology and implementing cost reductions. Operating expenses were reduced by 50% ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and ...

Investigators report that estradiol works as well as luteinizing hormone–releasing hormone agonists for testosterone suppression and have a much better side-effect profile.